Efficacy and Safety Study of ABT-384 in Subjects With Mild-to-Moderate Alzheimer's Disease
Clinical trial NCT01137526 · COMPLETED
Trial details
- NCT number
- NCT01137526
- Sponsor
- AbbVie (prior sponsor, Abbott)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-05-01
- Primary completion
- 2011-07-01
- Enrollment
- 267
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.